Biotechnology
Non-Esterified Fatty Acid Reagents Market

Non-Esterified Fatty Acid Reagents Market

Non-Esterified Fatty Acid Reagents Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

ID: PMRREP30673

Upcoming

Author : Pravin Rewale

Introduction

Non-esterified fatty acids are the molecules released from triglycerides as a result of enzyme lipase action which is then transported in the blood bound to albumin. Management of non-esterified fatty acids level is important in diabetic patients and the levels are also frequently increasing among the obese population.

The rising patient pool is likely to drive the non-esterified fatty acid testing and will be furthered propel the growth of non-esterified fatty acid reagent market. The fluctuation of the insulin level and poor diet will adversely affect the release of non-esterified fatty acids in the body which may develop cardiovascular disease.

Conditions like diabetes type 2/ insulin resistance, obesity, metabolic syndrome, and malignant diseases all are related to increased non-esterified fatty acids concentrations in the blood. This factor will boost the need for non-esterified fatty acid testing and is likely to contribute to the non-esterified fatty acid reagent market growth.

Additionally, from past few years, awareness has been raised among these population group which is likely to contribute to the growth of the non-esterified fatty acid reagent market.

According to the International Diabetes Federation, The diabetic population is expected to rise to 600 Mn by 2045. Around 79% of diabetic adults’ are from low- & middle-income countries. This factor will increase the non-esterified fatty acid testing and is likely to contribute to the non-esterified fatty acid reagent market growth.

Healthcare professionals recommend diabetic patients to regularly check body fat which will increase the testing demand and will boost the non-esterified fatty acid reagent market growth. According to the World Health Organization, approximately 1.9 Bn population aged 18 years and above were overweight, in 2016, globally.

The increasing obese population is expected to boost the need for non-esterified fatty acid testing and is expected to contribute to the non-esterified fatty acid reagent market growth over the coming years.